Disease | Gene | Inheritance | Clinical features | Laboratory tests | Treatment |
---|---|---|---|---|---|
Ehlers-Danlos syndrome | COL1A1; COL1A2; COL3A1, COL5A1; COL5A2; TNXB, and others | AD and AR | Skin hyperextensibility with atrophic scarring, generalized joint hypermobility, exercise intolerance, muscle weakness, arterial rupture at young age, spontaneous sigmoid colon, or uterine rupture; MCAS and POTS may be associated | Molecular analysis#; Increased serum tryptase or urinary N-MH, PG metabolites, LTE4, ≥ 20 MCs per HPF in extracutaneous tissue biopsy in case of MCAS | Angiotensin receptor blocker and/or beta-blocker for aneurysm, pain relief drugs, physiotherapy, and rehabilitation therapy; Surgical intervention (aneurysm, dissection, organ rupture); Antihistamines, leukotriene antagonists, 5-lipoxygenese inhibitors, and PG blockers in case of MCAS |
Marfan syndrome | FBN1 | AD | Wrist and thumb sign, arachnodactyly, generalized joint hypermobility, anterior chest deformity (pectus excavatum and/or carinatum), pneumothorax, myopia, ectopia lentis, aortic root dilatation | Molecular analysis#. Aortic dilation (Z-score ≥ 2 SD) on echocardiography | Angiotensin receptor blocker and/or b-blocker for aneurysm, pain relief drugs, physiotherapy, and rehabilitation therapy; Surgical intervention (aneurysm, dissection) |
Loeys-Dietz syndrome | TGFBR1; TGFBR2; TGFB2; TGFB3; SMAD3; SMAD2. | AD | Generalized joint hypermobility, chest deformity, scoliosis, bifid (split or forked) uvula, cleft palate, hypertelorism; Aortic root aneurysms, arterial tortuosity, dissections, mitral valve prolapse | Molecular analysis# | Angiotensin receptor blocker and/or b-blocker for aneurysm, pain relief drugs, physiotherapy, and rehabilitation therapy; Surgical intervention (aneurysm, dissection) |